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http:WHAT THIS PAPER ADDS
This study investigates, for the ﬁrst time, the effect of carotid endarterectomy (CEA) on arterial stiffness. We
found that CEA improves peripheral arterial stiffness, providing evidence that CEA has cardiovascular risk
beneﬁts beyond only direct cerebrovascular risk reduction.Objective: Carotid endarterectomy (CEA) reduces the risk of cerebrovascular events due to the presence of
atherosclerotic plaque in the internal carotid artery. Arterial stiffness is an indicator of cardiovascular risk and
strongly associates with the development of atherosclerosis. This study aims to assess the short-term effect of
CEA on arterial stiffness and haemodynamics.
Design: Prospective observational study.
Methods: Measurements of arterial stiffness and haemodynamics, including carotid-femoral pulse wave velocity
(cfPWV), carotid-radial PWV (crPWV), augmentation pressure, augmentation index, subendocardial viability ratio,
central pressures and pulse pressure ampliﬁcation, were performed pre- and 6 weeks post-CEA on both surgical
and non-surgical sides.
Results: Fifty-nine patients completed the study (n ¼ 46 men, age 68.9  10.1 years). crPWV was decreased after
CEA on the surgical (P ¼ 0.01) and non-surgical side (P ¼ 0.0008), AIx75 tended to decrease only on the surgical
side (P ¼ 0.06). cfPWV did not change signiﬁcantly on either side.
Conclusion:We assessed, for the ﬁrst time, the short-term effect of CEA on arterial stiffness and haemodynamics.
CEA improved peripheral but not central arterial stiffness. This study provides evidence for signiﬁcant changes in
certain arterial stiffness and haemodynamic parameters. Longer-term follow-up will assess whether these
changes are sustained and whether CEA is associated with further haemodynamic beneﬁts.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Augmentation indexArterial stiffness has previously been shown to be an
independent indicator of symptomatic cardiovascular (CV)
disease and events as well as a measure of vascular
health.1,2 In fact, a strong correlation between arterial
stiffness and development of atherosclerosis at different
sites of the arterial system has been shown in previous
studies.3,4 Arterial stiffness determines how quickly the
pulse wave generated by the contracting heart travels to
the periphery and is reﬂected back. Several arterial stiffness
and haemodynamic measurements exist. Carotid-femoral
pulse wave velocity (cfPWV) measures the speed of theresponding author. S.S. Daskalopoulou, Department of Medicine,
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//dx.doi.org/10.1016/j.ejvs.2013.02.012pulse wave along the path from the heart through the
ascending and descending aorta to the iliac and the femoral
arteries (elastic central arteries) and is therefore considered
a measure of central stiffness. cfPWV has the most evidence
to support its predictive value.1,2 Carotid-radial PWV
(crPWV) measures the speed of the pulse wave along the
path of the heart to the brachial and radial arteries
(muscular peripheral arteries). crPWV represents peripheral
stiffness.
In addition to PWV, arterial stiffness can be assessed by
pulse wave analysis (PWA), which measures several
parameters including augmentation pressure (AP, due to
reﬂected waves), augmentation index (AIx, deﬁned as AP
divided by pulse pressure (PP)), AIx corrected for a heart
rate (HR) of 75 beats per minute (bpm) (AIx75), sub-
endocardial viability ratio (SEVR, myocardial oxygen supply/
demand ratio) and central blood pressures (BP (aortic BP)).
The pressure waveform recorded at any site of the arterial
tree is the sum of the forward-travelling waveform
(generated by pump ejection) and the backward-travelling
J. Gorgui et al. 549wave (the ‘echo’ of the forward-travelling wave reﬂected at
peripheral sites). AP is the pressure added to the forward-
travelling wave by the backward-travelling wave and
represents the extra pressure with which the left ventricle
must cope. Increased wave reﬂection (backward-travelling
wave) causes increased AP. AIx is a composite measure of
the magnitude and the timing of wave reﬂection. Larger
values of AIx indicate increased arterial stiffness and central
BP. A previous study showed that a 10% increase in AIx75 is
associated with 31.4% increased risk of all-cause mortality
and other CV diseases.5
The presence of atherosclerotic plaques in the internal
carotid artery (ICA) is a known aetiological factor for cere-
brovascular events, more particularly stroke, transient
ischaemic attacks (TIAs), and amaurosis fugax (AF). Carotid
endarterectomy (CEA) is currently the main surgical inter-
vention used to treat high-grade carotid atherosclerosis.
Indeed, guidelines suggest CEA for symptomatic and asymp-
tomatic (with low surgical risk) carotid stenosis 70%
according to theNorth AmericanCarotid Endarterectomy Trial
study (NASCET) method of assessing carotid stenosis.6,7 Since
atherosclerosis has previously been associatedwith increased
arterial stiffness, we sought to assess the short-term changes
in arterial stiffness and haemodynamic parameters in patients
with high-grade carotid stenosis undergoing CEA.
METHODS
Ethics approval for the study has been obtained by the
McGill University Institutional Review Board. Written
informed consent was obtained for all participants.
Participants
Patients scheduled for a CEA were recruited in the preoper-
ative clinics of the Royal Victoria Hospital and the Jewish
General Hospital in Montreal, Canada. Subjects were
excluded if they had a history of any intervention on their
ipsilateral carotid arteries. Information on cerebrovascular
symptomology, family and personal medical history including
history of hypertension, dyslipidaemia, diabetes, medication
intake, current or past smoking habits was assessed in all
enrolled patients through (1) patient interview, (2) a detailed
questionnaire and (3) patient medical records. This infor-
mation was cross-checked between sources to ensure accu-
racy. Anthropometric measurements (height and weight)
were performed to calculate body mass index (BMI).
Study design and protocol
Arterial stiffness and haemodynamic assessments were
performed within a week before CEA and at the 6-week
surgical follow-up (following the clinical trajectory of the
patient). All measurements were performed on the surgical
and non-surgical side. For each participant, pre- and post-
CEA measurements were performed at the same time
during the morning to minimise the effect of the circadian
cycle.8 Participants were told to abstain from any caffein-
ated beverages, ethanol intake and smoking for at least 12 h
prior to the assessments. Immediately prior to theassessments, subjects were asked to lie in a supine position
for 10 min in a temperature (20  1 C) and humidity
(60  5%) controlled environment.Arterial stiffness and haemodynamic measurements
Peripheral BP was measured using cuff sphygmomanometry
(HEM-705CP, Omron Corp., St. Charles, IL, USA) according to
the Canadian hypertension guidelines.9 A total of three
measurementswere performed; the ﬁrstwas discardedwhile
the other two were averaged. Applanation tonometry was
performed to measure cfPWV, crPWV and PWA using
a SphygmoCor (AtCor Medical, Sydney,VIC, Australia) device.
cfPWV (central stiffness) and crPWV (peripheral stiffness)
measurements were performed with applanation tonometry
in combination with a three-lead electrocardiogram. Two
pulse waves were recorded at two distinct sites: ﬁrst distally
either at the femoral (for cfPWV) or at the radial artery (for
crPWV), then proximally at the common carotid artery.
Distance was measured as the difference between the
distance from the suprasternic notch to the distal artery and
the distance between the carotid and suprasternic notch.10
For PWA, a sequence of radial waveforms over a 10-s
period was used to generate an average radial artery
pressure waveform. Multiple recordings were performed in
order to obtain a quality control index >85% as established
by SphygmoCor quality control system.11 Using a previously
validated transfer function and the averaged radial artery
waveform, a corresponding aortic pressure waveform was
derived.10 Through this aortic waveform, the software
automatically calculated the following measurements:
 AIx and AIx75, determined by the augmentation of
systolic pressure due to the reﬂected wave (AP) as
a percentage of aortic PP: AIx ¼ (AP/PP)*100 and
adjusted for an HR of 75 bpm;
 SEVR, determined by: pressure area under the curve
(AUC) during diastole/AUC during systole; and
 aortic pressures, allowing us to also calculate PP
ampliﬁcation (PPA) using the following formula:
PPA ¼ peripheral PP/aortic PP.
Additional information and explanation of evaluated
parameters can be found in Supplementary Table 1.
Applanation tonometry has previously been established as
highly reproducible (intra- and inter-operator) in healthy as
well as diseased populations.12,13
PWV measurements were performed in duplicate and
averaged for statistical analyses. Reported values are
mean  standard deviation (SD). All arterial stiffness and
haemodynamic measurements for the surgical side were
performed on the ipsilateral side, whereas for the non-
surgical side the measurements were performed on the
contralateral side.Statistical analyses
Data were analysed using SAS version 9.2 (SAS Institute, 100
SAS Campus Dr, Cary, NC, USA). Initially repeated measures
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separately on the surgical and non-surgical sides with the
visit (pre-CEA and post-CEA) as the variable of interest. To
determine if the preepost-CEA changes were signiﬁcantly
different between the surgical and non-surgical sides,
repeated measures analysis of variance was performed on
all data together with the surgical and non-surgical side
being the variable of interest. Adjustment for age, sex and
pre-CEA mean arterial pressure (MAP) was performed in
these analyses. Signiﬁcance was considered as P < 0.05.
RESULTS
We recruited 66 consecutive patients scheduled for CEA.
Seven patients were excluded because of arterial stiffness
measurements of inadequate quality due to atrial ﬁbrilla-
tion (sinus rhythm is required for high-quality readings).
Patient baseline and clinical characteristics are presented in
Table 1. cfPWV did not signiﬁcantly change on either side.
crPWV decreased after CEA on both surgical (P ¼ 0.01,
Table 2) and non-surgical sides (P ¼ 0.0008, Table 2),Table 1. Baseline characteristics of participants (n ¼ 59).
Parameters
Age, yrs (mean  SD) 68.94  10.14
Gender (M/W) 46/13
BMI, kg.m2 (mean  SD) 26.87  4.01
Symptomatology, n (%)
Asymptomatic 16 (27.12)
Stroke 17 (28.81)
TIA 16 (27.12)
AF 10 (16.95)
Surgical side, n (%)
Right 28 (47.46)
Left 31 (52.54)
Stenosis, n (%)
Surgical side
70e82% 11 (20.00)
83e99% 44 (80.00)
Non-surgical side
0e49% 21 (38.18)
50e69% 8 (14.55)
70e82% 20 (36.36)
83e99% 6 (10.91)
CVD history, n (%)
CAD history 24 (40.68)
PAD history 27 (45.76)
Risk factors, n (%)
Hypertension 49 (83.05)
Hyperlipidaemia 50 (84.75)
Diabetes 10 (16.95)
Former smoker 45 (76.27)
Current smoker 11 (18.64)
Treatment, n (%)
Anti-platelets 48 (81.36)
Lipid lowering 46 (77.97)
Anti-hypertensive 42 (71.86)
Anti-diabetic 10 (16.95)
TIA e transient ischaemic attack, AF e amaurosis fugax, CVD e
cardiovascular disease, CAD e coronary artery disease, PAD e
peripheral arterial disease.although the decrease was signiﬁcantly greater on the
surgical side (P < 0.0001, Table 3). There was a trend for
a decrease in AIx75 on the surgical side (P ¼ 0.06) while no
signiﬁcant difference on the non-surgical side was observed.
However, the difference of the change in AIx75 (pre- to
post-CEA) between the two sides was signiﬁcant (P ¼ 0.01)
(Table 3).DISCUSSION
To our knowledge, we have assessed for the ﬁrst time the
effect of CEA on arterial stiffness and haemodynamics. We
found that peripheral arterial stiffness (crPWV) was signiﬁ-
cantly decreased on both the surgical and non-surgical sides
after CEA, while cfPWV was not signiﬁcantly changed.
Furthermore, AIx75 (wave reﬂections and systemic arterial
stiffness) was trending towards a signiﬁcant decrease on the
surgical side only.
cfPWV is considered the ‘gold standard’ parameter of
arterial stiffness and has been associated with increased risk
of all-cause mortality, morbidity and CV disease.1 Variations
of cfPWV indicate changes in aortic stiffness. However, we
found no signiﬁcant change in cfPWV 6 weeks post-CEA
when measured on the surgical or non-surgical side. The
aorta is an elastic artery that is less affected by acute
changes than by chronic factors, such as ageing or
hypertension.14
In this study, we found a signiﬁcant decrease in crPWV on
both sides following CEA. This decrease in crPWV might be
explained by different possible mechanisms. First, it could
be attributed to mechanical changes due to the physical
removal of the carotid atherosclerotic plaque. A study by
Gnasso et al. compared shear stress in carotid arteries with
and without atherosclerotic plaque.15 They reported lower
shear stress in arteries with atherosclerotic plaques versus
the contralateral side, as explained by increased diameter of
the carotid artery and decreased blood ﬂow velocity in the
presence of plaque.15 For this reason, carotid plaque
removal might lead to increased shear stress in the artery.
Augmented shear stress has been shown to increase
phosphorylation of endothelial nitric oxide synthase (eNOS),
which results in increased production and release of NO
into the systemic circulation.16 Peripheral, muscular arteries
are more sensitive to vasoactive agents than central, elastic
arteries due to their differential composition.17 Thus,
increased NO release leads to a greater vasodilation
peripherally,18,19 thereby reducing (improving) crPWV. On
the other hand, reduced inﬂammation post-CEA may also
be responsible for decreased crPWV. Inﬂammation has been
shown to be increased in atherosclerosis and to worsen
arterial stiffness parameters.20e24 Atherosclerotic plaque
secretes various mediators of inﬂammation.25 A study by
Dosà et al. assessed changes in the levels of high-sensitivity
C-reactive protein (hs-CRP) and ﬁbrinogen, pre-CEA, as well
as 6 weeks and 3 months post-CEA; plasma hs-CRP and
ﬁbrinogen levels were signiﬁcantly decreased at 6 weeks
and 3 months following CEA.26 Furthermore, lower plasma
CRP levels are associated with a signiﬁcant improvement of
Table 2. Pre- and post-CEA arterial stiffness and haemodynamics on surgical and non-surgical sides.
Parameter Surgical Non-surgical
Pre-CEA Post-CEA P value Pre-CEA Post-CEA P value
cfPWV (m/s) 10.97  2.67 10.84  2.28 0.846 10.83  2.52 10.65  2.44 0.346
crPWV (m/s) 8.08  1.13 7.62  1.13 0.018a 8.03  1.08 7.72  1.23 0.0008a
AP (mmHg) 16.36  6.94 15.63  6.28 0.413 16.83  7.93 16.09  7.85 0.174
AIx75 (%) 25.51  8.58 24.41  7.30 0.062b 25.0  7.38 24.51  9.26 0.120
SEVR (%) 153.68  28.85 149.55  28.17 0.841 154.89  31.76 148.22  26.82 0.410
Central SBP (mmHg) 120.81  14.86 121.40  15.76 0.382 122.86  14.85 120.97  15.53 0.144
Central DBP (mmHg) 69.73  10.28 70.12  10.08 0.058b 70.33  9.48 68.75  10.01 0.186
Central PP (mmHg) 51.08  13.63 51.28  13.08 0.618 52.54  16.08 52.22  13.20 0.427
Peripheral SBP (mmHg) 131.00  15.86 132.33  16.82 0.582 132.83  14.95 131.45  15.85 0.193
Peripheral DBP (mmHg) 68.38  10.03 69.33  9.81 0.039a 69.60  9.49 68.03  9.82 0.149
Peripheral PP (mmHg) 62.63  14.46 63.00  14.66 0.445 63.23  16.67 63.43  13.57 0.644
MAP (mmHg) 89.25  10.22 90.33  10.53 0.111 90.66  8.54 89.17  10.35 0.112
HR (bpm) 62.55  10.74 63.75  11.73 0.201 62.31  10.49 63.97  11.17 0.997
PP ampliﬁcation 1.24  0.14 1.24  0.11 0.882 1.22  0.09 1.23  0.10 0.333
cfPWV e carotid-femoral pulse wave velocity; crPWV e carotid-radial PWV; SBP e systolic blood pressure; DBP e diastolic BP; PP e pulse
pressure; HR e heart rate; bpm e beats per minute; SEVR e subendocardial viability ratio; AP e augmentation pressure; AIx75 e
augmentation index adjusted for HR of 75 bpm. P Values were adjusted for sex, age and mean arterial pressure (MAP).
a Signiﬁcant results.
b Results trending towards signiﬁcance.
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removal of an atherosclerotic plaque can lead to decreased
secretion of inﬂammatory mediators, which may in turn
increase vasodilation.
We also assessed the effect of CEA on several PWA
parameters, namely AIx75, AP and central BPs. AIx, a marker
of systemic wave reﬂection, has previously been shown to
be a predictor of future CV events.1,28,29 Importantly,
systemic wave reﬂection can be affected by any degree of
stenosis, even haemodynamically non-signiﬁcant.30 A
decrease in AIx75 (0.9% on the surgical side and 0.5%
Table 3. Differences in the pre- and post-CEA change in both
surgical and non-surgical sides.
Parameter P value
cfPWV (m/s) 0.398
crPWV (m/s) <0.0001a
AP (mmHg) 0.126
AIx75 (%) 0.017a
SEVR (%) 0.455a
Central SBP (mmHg) 0.070b
Central DBP (mmHg) 0.013a
Central PP (mmHg) 0.828
Peripheral SBP (mmHg) 0.143
Peripheral DBP (mmHg) 0.007a
Peripheral PP (mmHg) 0.818
MAP (mmHg) 0.013a
HR (bpm) 0.103
PP ampliﬁcation 0.574
cfPWV e carotid-femoral pulse wave velocity; crPWV e carotid-
radial PWV; SBP e systolic blood pressure; DBP e diastolic BP;
PP e pulse pressure; HR e heart rate; bpm e beats per minute;
SEVR e subendocardial viability ratio; AP e augmentation
pressure; AIx75 e augmentation index adjusted for HR of
75 bpm. P Values were adjusted for sex, age and mean arterial
pressure (MAP).
a Signiﬁcant results.
b Results trending towards signiﬁcance.on the non-surgical side) has been noted post-CEA, sug-
gesting that CEA may have a beneﬁcial effect on wave
reﬂection. Although in our study the decrease in AIx75 was
not signiﬁcant, it is not unexpected given that AIx75
captures both peripheral (signiﬁcantly decreased) and
central wave reﬂections (unchanged).
SEVR represents myocardial oxygen supply/demand
ratio.31,32 SEVR has previously been associated with
a number of conditions, such as coronary artery disease,
decreased coronary ﬂow reserve in patients with healthy
coronary arteries, type 1 and type 2 diabetes and decreased
renal function.3,14,33e35 We observed no signiﬁcant changes
in SEVR either on the surgical or on the non-surgical sides
post-CEA. This is most likely because the presence of carotid
plaque does not appreciably increase the afterload on the
heart and, therefore, does not change oxygen demand of
the myocardium.
There are limitations to this study. Applanation tonom-
etry is an operator-dependent technique. However, our
laboratory has extensive experience with this technique and
the SphygmoCor system has several internal quality-control
measures. The patients included in the study have co-
morbidities and the vast majority are taking multiple
medications. Although we did not have the power to adjust
for these possible confounders, it is unlikely that our results
would have changed given that the vast majority of the
patients were treated preoperatively without any changes
within the 6-week follow-up period. We adjusted for age,
sex and MAP which are known factors that affect arterial
stiffness. Furthermore, removal of the atherosclerotic pla-
que may alter cerebral haemodynamics, through acute
increase of cerebral blood ﬂow. Previous studies have
shown that changes in cerebral haemodynamics are
restored shortly post-CEA.36e39 As we have not assessed
these changes in our study, we cannot rule out the possible
implication of these parameters on our results. Moreover,
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any effect on arterial stiffness and haemodynamics, we did
not investigate potential mechanisms. We also measured
post-CEA arterial stiffness at one time-point (6 weeks).
Therefore we are not able to determine if CEA has a bene-
ﬁcial effect on arterial stiffness or haemodynamics in the
longer term. However, long-term follow-ups and investi-
gating mechanisms of these changes are part of our
ongoing study.CONCLUSION
We have assessed, for the ﬁrst time, the effect of CEA on
arterial stiffness and haemodynamics. We found that while
CEA did not appreciably affect many parameters of vessel
haemodynamics and central arterial stiffness 6 weeks post-
CEA, there was an improvement of peripheral arterial
stiffness. Future studies will need to assess whether the
observed changes are sustained and whether CEA is asso-
ciated with further haemodynamic beneﬁts in the long
term.
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